Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03027037 · ClinicalTrials.gov registry record
Perinatal Emotion and Relationships Longitudinal Study
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 150
- Enrollment target
NCT03027037: Completed study, sponsored by University of Colorado, Boulder.
NCT03027037 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03027037 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study, funded by the John Templeton Foundation, will examine birth and the early postpartum period (BEPP) as a transformative life experience that may shift women's experience of emotion in such ways as to a) support enhanced other-oriented emotions and b) underlie risk or resilience from psychopathology.
Primary Outcome
Assessed via interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-01 |
What the finished NCT03027037 record still lists
NCT03027037 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03027037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03027037 about?
NCT03027037 is a clinical study titled "Perinatal Emotion and Relationships Longitudinal Study". This study, funded by the John Templeton Foundation, will examine birth and the early postpartum period (BEPP) as a transformative life experience that may shift women's experience of emotion in such ways as to a) support enhanced other-oriented emotions and b) underlie risk or resilience from psych...
What is the current status of trial NCT03027037?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2015-11. Estimated completion is 2018-01.
Who is sponsoring clinical trial NCT03027037?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia